Stratos Wealth Partners LTD. reduced its stake in shares of Steris PLC (NYSE:STE) by 1.3% in the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 32,523 shares of the medical equipment provider’s stock after selling 413 shares during the quarter. Stratos Wealth Partners LTD.’s holdings in Steris were worth $4,164,000 as of its most recent filing with the SEC.
Several other hedge funds also recently bought and sold shares of the stock. Advisory Services Network LLC increased its position in Steris by 26.0% during the fourth quarter. Advisory Services Network LLC now owns 427 shares of the medical equipment provider’s stock worth $45,000 after acquiring an additional 88 shares during the period. Bbva Compass Bancshares Inc. lifted its position in Steris by 3.9% during the 4th quarter. Bbva Compass Bancshares Inc. now owns 2,389 shares of the medical equipment provider’s stock worth $255,000 after buying an additional 89 shares in the last quarter. State Treasurer State of Michigan lifted its position in Steris by 0.3% during the 1st quarter. State Treasurer State of Michigan now owns 30,200 shares of the medical equipment provider’s stock worth $3,867,000 after buying an additional 100 shares in the last quarter. Security Asset Management lifted its position in Steris by 1.3% during the 1st quarter. Security Asset Management now owns 8,179 shares of the medical equipment provider’s stock worth $1,047,000 after buying an additional 104 shares in the last quarter. Finally, Neuburgh Advisers LLC lifted its position in Steris by 1.4% during the 4th quarter. Neuburgh Advisers LLC now owns 9,592 shares of the medical equipment provider’s stock worth $1,025,000 after buying an additional 132 shares in the last quarter. Institutional investors and hedge funds own 86.81% of the company’s stock.
NYSE:STE traded up $4.90 on Thursday, hitting $135.54. 163,776 shares of the stock were exchanged, compared to its average volume of 426,131. The stock has a market capitalization of $10.58 billion, a P/E ratio of 27.72 and a beta of 1.06. Steris PLC has a 52 week low of $99.14 and a 52 week high of $134.99. The company has a current ratio of 2.56, a quick ratio of 1.99 and a debt-to-equity ratio of 0.40.
The company also recently disclosed a quarterly dividend, which will be paid on Friday, June 28th. Shareholders of record on Wednesday, June 12th will be issued a dividend of $0.34 per share. The ex-dividend date of this dividend is Tuesday, June 11th. This represents a $1.36 annualized dividend and a yield of 1.00%. Steris’s dividend payout ratio is currently 27.81%.
Several analysts have weighed in on the company. Zacks Investment Research raised Steris from a “sell” rating to a “hold” rating in a report on Thursday, March 28th. KeyCorp boosted their price objective on Steris from $135.00 to $138.00 and gave the stock an “overweight” rating in a report on Wednesday. Stephens boosted their price objective on Steris from $135.00 to $150.00 and gave the stock an “overweight” rating in a report on Wednesday. Finally, JMP Securities reissued a “buy” rating and set a $135.00 price objective on shares of Steris in a report on Thursday, February 14th. Five investment analysts have rated the stock with a buy rating, Steris presently has a consensus rating of “Buy” and a consensus price target of $145.20.
In other news, Director Cynthia L. Feldmann sold 2,037 shares of the company’s stock in a transaction dated Wednesday, February 20th. The stock was sold at an average price of $122.51, for a total value of $249,552.87. Following the completion of the sale, the director now directly owns 10,700 shares of the company’s stock, valued at approximately $1,310,857. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CEO Walter M. Rosebrough, Jr. sold 50,000 shares of the company’s stock in a transaction dated Thursday, March 21st. The shares were sold at an average price of $125.00, for a total value of $6,250,000.00. Following the completion of the sale, the chief executive officer now directly owns 98,895 shares of the company’s stock, valued at $12,361,875. The disclosure for this sale can be found here. Insiders have sold a total of 55,646 shares of company stock valued at $6,939,093 over the last three months. Company insiders own 2.38% of the company’s stock.
TRADEMARK VIOLATION NOTICE: This news story was originally published by Dakota Financial News and is the sole property of of Dakota Financial News. If you are reading this news story on another site, it was illegally stolen and reposted in violation of U.S. and international trademark & copyright legislation. The legal version of this news story can be accessed at https://dakotafinancialnews.com/2019/05/16/stratos-wealth-partners-ltd-decreases-position-in-steris-plc-ste.html.
STERIS plc provides infection prevention and other procedural products and services worldwide. The company operates in four segments: Healthcare Products, Healthcare Specialty Services, Life Sciences, and Applied Sterilization Technologies. The Healthcare Products segment offers cleaning chemistries and sterility assurance products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operations of a sterile processing department; and equipment used in the operating room, including surgical tables, lights, equipment management services, and connectivity solutions.
Featured Article: Systematic Risk and Investors
Want to see what other hedge funds are holding STE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Steris PLC (NYSE:STE).
Receive News & Ratings for Steris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Steris and related companies with MarketBeat.com's FREE daily email newsletter.